Webinars organized by Candoris are interactive, often in Q&A format, concrete and to the point.
Upcoming Webinars:
The Coho ESG US strategy is a high conviction, concentrated, high alpha generating strategy, which due to its contrarian performance pattern (outperformance in down-markets) diversifies your portfolio, offers protection and adds value over ETF’s.
The Orchard US Small Cap Value strategy is a high conviction, concentrated, high alpha generating strategy that identifies companies that trade at a significant discount to where they should trade at and have one or multiple catalyst to unleash this intrinsic value.
The DSM Global Growth strategy is a high conviction, concentrated, high alpha generating strategy that invests in companies that have high earnings growth. A strict valuation discipline differentiates DSM from other growth managers and allocation to EM can be up to 40%.
The Eleva Leaders Small & Mid Cap Europe strategy is a high conviction, concentrated, high alpha generating growth strategy with a high active share managed by a female investment team. Majority of outperformance comes from stock selection.
The VanEck Emerging Markets strategy is a high conviction, relative concentrated, high alpha generating growth strategy that invests in the future of emerging markets. With 40% in small & mid cap it is a true all cap strategy.
The DSM US Large Cap Growth strategy is a high conviction, concentrated, high alpha generating strategy that invests in companies that have high earnings growth. A strict valuation discipline differentiates DSM from other growth managers.
The SiM US HY strategy is a high conviction, concentrated, high alpha generating strategy with a high active share and a pragmatic flexible approach to investing in US HY. Over the cycle the strategy aims to outperform the benchmark with 2% annualized with similar risk characteristics.
The VanEck Unconstrained Emerging Market Debt strategy is one of the few truly unconstrained EMD managers with a unique bottom up approach aiming to optimize portfolio risk using the distinct risk and return characteristics of each of the three EMD sub universus (HC, LC, Corporates).
The PAM US Senior Loan strategy is a selective relatively concentrated strategy investing in larger and more broadly syndicated loans. The strategy outperforms during corrections and aims to outperform the benchmark with 1.5% annualized while taking less risk.
Candoris is a small entrepreneurial company that brings unique investment strategies with a long-term proven investment process at the doorstep of institutional investors and wholesale distributors (www.candoris.nl). The asset managers we work with are typically employee owned boutiques with concentrated high-alpha generating strategies and long track records. Next to that we create better access for investors by setting up UCITS and Alternative funds under our own Candoris fund ranges (www.candoris-fundsolutions.com). We have 27 investors that invested a total of over USD 1.6 Billion with our managers. We market in The Netherlands, Norway, Sweden, Finland, Denmark, Iceland, The Baltics, Germany, Austria, Switzerland and Ireland.
In Switzerland, the Fund is considered foreign investment schemes pursuant to Art. 119 of the Swiss Federal Collective Investment Schemes Act (CISA). No application has been submitted to the Federal Financial Market Supervisory Authority (FINMA) to obtain approval within the meaning of Art. 120 CISA to offer or distribute the investment in or from Switzerland to “Non-Qualified Investors”, and no other steps have been taken in this direction. Consequently, investors do not benefit from the specific investor protection and/or FINMA supervision pursuant to the CISA and its implementing ordinances.
Any offer or sale must therefore be in strict compliance with Swiss law, and in particular with the provisions of the Collective Investment Schemes Act and its implementing ordinances, and FINMA circular 2013/9 on distribution of collective investment schemes. No person or entity is authorized to offer or sell the Shares or distribute any Fund Documentation, including the Prospectus, the Articles of Incorporation and annual reports issued by the Fund from time to time or promotional material pertaining to the Fund in or from Switzerland other than to “Qualified Investors”, as defined in Article 10 of the CISA and Articles 6 and 6a of the CISO and any circulars issued by FINMA.
The Fund has appointed as Swiss Representative Oligo Swiss Fund Services SA, Av. Villamont 17, 1005 Lausanne, Switzerland, Tel: +41 21 311 17 77, email: info@oligofunds.ch. The Fund’s paying agent is Helvetische Bank AG. Any Fund Documentation may be obtained free of charge from the Swiss Representative in Lausanne. In respect of the Shares distributed in or from Switzerland, the place of performance and jurisdiction is at the registered office of the Swiss Representative.
This Candoris website is only intended for MiFID professional investors. By accepting this disclaimer, you agree with the content of the disclaimer and acknowledge that you are a MiFID professional investor.
The information contained in these pages must not be used or relied upon by retail investors.
By clicking accept you acknowledge that you have read and understood the important information such as our Privacy policy and our cookies policy.
The information and prospectuses on this website should neither be regarded as an offer nor a solicitation to buy, sell or otherwise deal with any investment referred to herein and is not intended for distribution to, or use by, any person in any country (including the United States) where the investment funds and services referred to are not authorised or registered for distribution or in which the dissemination of information on the funds or services is forbidden.
Please check the fund fact sheet to find out in which countries the funds are authorised or registered for distribution. The funds and services may not be suitable for all investors and offering them may not be allowed by local law or regulations. Investors should read the prospectus and take advice from their own independent advisors before making an investment decision and should be aware of local laws governing investments. None of the funds are registered under the Securities Act 1933 of the United States nor under the Investment Company Act of 1940 of the United States. The details on these funds as shown are not an offer for sale or to be sold in the United States, its territories, possessions or protectorates under its jurisdiction, nor to nationals, citizens or residents in any of those areas.
The value of your investment may rise or fall. Past performance is not indicative of future results. Some funds on the website may make use of leverage facilities, derivatives or invest up to 100% of their total net assets in unlisted securities, possibly deriving from so-called developing (emerging) countries. This can involve specific risks of which investors should be aware, among which risks related to political and economic stability, currency exchange rates as well as applicable foreign taxes and accounting standards. Any other products or securities that are mentioned on this website have their own particular terms and conditions, which also should be consulted before entering into any transaction.
The content of this website is based upon sources of information believed to be reliable. However, no guarantee, warranty or representation, express or implied, is given as to the accuracy or completeness of such information; and Candoris B.V. ,nor any of its officers, directors or employees accept any liability or responsibility in respect to the information or any recommendations expressed herein. The information on this website is subject to change without notice.
The content of this website is owned or licensed by Candoris B.V. and its subsidiaries or its third-party providers and is protected by applicable copyrights, trademarks, and/or other intellectual property rights. The content is only meant for personal, non-commercial use and may not be multiplied and/or distributed in any manner.
Candoris B.V. and its subsidiaries guarantee that the data of persons accessing the website will be treated confidentially in accordance with applicable data protection regulations. Such data will not be made available to third parties without the approval of the persons accessing the website, unless Candoris B.V. and/or any of its subsidiaries are legally obliged to do so.
This disclaimer and any claims arising out of or in connection with the terms and conditions of this disclaimer are governed by Dutch law.